WO2004050834A3 - Gpc99 et gpc99a: compositions et methodes de traitement du cancer - Google Patents

Gpc99 et gpc99a: compositions et methodes de traitement du cancer Download PDF

Info

Publication number
WO2004050834A3
WO2004050834A3 PCT/US2003/037813 US0337813W WO2004050834A3 WO 2004050834 A3 WO2004050834 A3 WO 2004050834A3 US 0337813 W US0337813 W US 0337813W WO 2004050834 A3 WO2004050834 A3 WO 2004050834A3
Authority
WO
WIPO (PCT)
Prior art keywords
gpc99a
gpc99
compositions
methods
treating cancer
Prior art date
Application number
PCT/US2003/037813
Other languages
English (en)
Other versions
WO2004050834A2 (fr
Inventor
Ronan C O'hagan
Karuppiah Kannan
Rijian Wang
Original Assignee
Genpath Pharmaceuticals Inc
Ronan C O'hagan
Karuppiah Kannan
Rijian Wang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genpath Pharmaceuticals Inc, Ronan C O'hagan, Karuppiah Kannan, Rijian Wang filed Critical Genpath Pharmaceuticals Inc
Priority to AU2003298708A priority Critical patent/AU2003298708A1/en
Publication of WO2004050834A2 publication Critical patent/WO2004050834A2/fr
Publication of WO2004050834A3 publication Critical patent/WO2004050834A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2869—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against hormone receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

L'invention concerne des compositions et des méthodes de traitement d'états d'hyperprolifération, tels que le cancer, à l'aide de réactifs liés au gène GPC99 ou GPC99a.
PCT/US2003/037813 2002-11-27 2003-11-26 Gpc99 et gpc99a: compositions et methodes de traitement du cancer WO2004050834A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003298708A AU2003298708A1 (en) 2002-11-27 2003-11-26 GPC99 AND GPC99a: METHODS AND COMPOSITIONS FOR TREATING CANCER

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42987702P 2002-11-27 2002-11-27
US60/429,877 2002-11-27

Publications (2)

Publication Number Publication Date
WO2004050834A2 WO2004050834A2 (fr) 2004-06-17
WO2004050834A3 true WO2004050834A3 (fr) 2004-12-02

Family

ID=32469383

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/037813 WO2004050834A2 (fr) 2002-11-27 2003-11-26 Gpc99 et gpc99a: compositions et methodes de traitement du cancer

Country Status (2)

Country Link
AU (1) AU2003298708A1 (fr)
WO (1) WO2004050834A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7202011B2 (ja) 2017-09-13 2023-01-11 キッズウェル・バイオ株式会社 抗ｒａｍｐ２抗体

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0521139D0 (en) * 2005-10-18 2005-11-23 Univ Sheffield Therapeutic agent
GB0708002D0 (en) * 2007-04-25 2007-06-06 Univ Sheffield Antibodies
JP5099856B2 (ja) * 2007-11-26 2012-12-19 独立行政法人科学技術振興機構 代謝症候群の治療もしくは予防剤、検査方法、検査薬、及び代謝症候群の治療薬の候補化合物のスクリーニング方法
CN110075276A (zh) * 2019-03-29 2019-08-02 中国人民解放军陆军军医大学第一附属医院 Adm竞争性拮抗剂ama在抗胶质瘤血管生成治疗中的应用
CN110090297B (zh) * 2019-03-29 2021-05-14 中国人民解放军陆军军医大学第一附属医院 Adm竞争性拮抗剂ama在胶质瘤免疫治疗中的应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999033877A1 (fr) * 1997-12-24 1999-07-08 Immunex Corporation Adn et polypeptides v196

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999033877A1 (fr) * 1997-12-24 1999-07-08 Immunex Corporation Adn et polypeptides v196

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
FOORD S.M. ET AL: "RAMPs: accessory proteins for seven transmembrane domain receptors", TRENDS IN PHARMACOLOGIAL SCIENCE, vol. 20, May 1999 (1999-05-01), pages 184 - 187, XP004170237 *
MCLATCHIE L.M. ET AL: "RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor", NATURE, vol. 393, 1998, pages 333 - 339, XP002922193 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7202011B2 (ja) 2017-09-13 2023-01-11 キッズウェル・バイオ株式会社 抗ｒａｍｐ２抗体

Also Published As

Publication number Publication date
AU2003298708A8 (en) 2004-06-23
WO2004050834A2 (fr) 2004-06-17
AU2003298708A1 (en) 2004-06-23

Similar Documents

Publication Publication Date Title
WO2003008623A3 (fr) Analyse de methylation au moyen d'agents de synchronisation
WO2005027962A3 (fr) 4’-thionucleosides et composes d'oligomeres
WO2003066802A3 (fr) Analyse d'expression genique au moyen d'agents de croisement
WO2005014850A3 (fr) Systemes et procedes d'analyse de sequences d'acides nucleiques
EP2671581B8 (fr) Compositions et procédés pour le traitement du cancer
WO2004023092A3 (fr) Analyse et authentification genetiques
WO2007133290A8 (fr) Anticorps anti-ox40l et méthodes correspondantes
WO2007002204A3 (fr) Procedes de pyrosequencage et compositions associees
WO2003016475A3 (fr) Sequences d'acides nucleiques et d'acides amines intervenant dans la douleur
WO2006020768A3 (fr) Oligonucleotides chimiquement modifies
WO2007059041A3 (fr) Combinaisons et methodes d'utilisation d'un oligonucleotide immunomodulatoire
WO2005011592A3 (fr) Indazoles-o-glucosides substitues
WO2005012243A3 (fr) Indole-o-glucosides substitues
WO2004037988A3 (fr) Methodes de synthese de l'adn complementaire
WO2004080418A3 (fr) Composes d'acide nucleique pouvant inhiber l'angiogenese et la croissance tumorale
WO2008013589A3 (fr) Traitement de tumeurs exprimant ras
EP1545453A4 (fr) Procedes et reactifs pour le traitement d'infections du clostridium difficile et de maladies qui lui sont associees
WO2004044160A3 (fr) Compositions d'arn a interference avec muc1 et procedes derives
WO2005085188A3 (fr) Composes et procedes pour la therapie antitumorale
WO2003099217A3 (fr) Methodes de traitement d'infections bacteriennes et de maladies associees
WO2004058153A9 (fr) Methodes et compositions de traitement de cancer au moyen des genes 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883, 12238, 18057, 21617, 3922
WO2005009951A3 (fr) Cycloalcanes diphenyl-substitutes, compositions contenant ces composes, et procedes d'utilisation
WO2004087073A3 (fr) Traitement d'etats de demyelinisation
WO2006015191A3 (fr) Analogues de lonidamine multicycliques
WO2006127368A3 (fr) Methodes pour synthetiser des imidazotriazinones

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP